Charts of the Day: Twitter, Discovery, Mylan

Twitter will replace Monsanto in S&P 500 index; Discovery upgraded by MKM Partners from "neutral" rating to a "buy"; FDA approves Mylan's drug aimed at reducing risk of infections following chemo

What to read next